Income Statement
MARKER THERAPEUTICS, INC.
MRKR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | 0.21 | 0.21 | - | - | - | - | -6.22 | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | 0.21 | 0.21 | - | - | - | - | - | - |
|
Operating Expenses
|
16.44 | 17.71 | 17.89 | 38.96 | 40.72 | 29.35 | 22.74 | 148.38 | 11.66 | 8.49 | 6.16 | 3.37 | 6.22 | 0.51 |
|
Research & Development
|
11.80 | 13.47 | 10.42 | 26.14 | 27.79 | 18.88 | 12.76 | 7.95 | 5.25 | 3.80 | 1.71 | 0.19 | 1.06 | 0.20 |
|
Selling, General & Administrative
|
4.18 | 4.24 | 7.48 | 12.82 | 12.92 | 10.47 | 9.98 | 24.38 | 6.41 | 4.69 | 4.45 | 3.18 | 1.01 | 0.31 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-16.44 | -17.71 | -17.89 | -38.96 | -40.72 | -29.35 | -22.53 | -148.17 | -11.66 | -8.49 | -6.16 | -3.37 | -6.22 | -0.51 |
|
Non-Operating Income
|
-4.26 | -7.03 | -3.85 | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
0.59 | 0.44 | 0.54 | 0.25 | 0.01 | 0.15 | 1.08 | 0.25 | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-12.18 | -10.68 | -14.04 | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
-0.02 | 0.05 | -5.81 | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-12.16 | -10.73 | -8.24 | -29.93 | -41.88 | -28.71 | -21.43 | -147.96 | -10.98 | -2.46 | -34.07 | -30.88 | -5.86 | -2.03 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-16.44 | -17.71 | -17.89 | -36.17 | -38.57 | -28.87 | -22.42 | -148.17 | -11.66 | -8.49 | -6.16 | -3.37 | -6.22 | -0.51 |
|
Earnings Per Share (Basic)
|
-0.79 | -1.19 | -0.94 | -3.58 | -0.55 | - | - | - | -1.16 | -0.36 | - | - | - | - |
|
Diluted EPS
|
-0.79 | -1.19 | -0.94 | -3.58 | -0.55 | - | - | - | -1.16 | -0.72 | - | - | - | - |
|
Weighted Average Shares
|
15.31 | 8.98 | 8.81 | 8.35 | 76.51 | 47.04 | 45.59 | 19.09 | 9.45 | 6.89 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
15.31 | 8.98 | 8.81 | 8.35 | 76.51 | - | - | - | 9.45 | 7.42 | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | -30.82 | - | - |